Therapixel: Using AI to improve breast cancer detection

AI-powered MammoScreen © Therapixel

Therapixel is raising €15m for commercial expansion of its AI-powered MammoScreen that gives accurate breast cancer screening results within minutes

French medtech Therapixel is gearing up to boost the clinical adoption of its award-winning MammoScreen across Europe and the US. The AI-powered breast cancer detection software enables radiologists to read digital mammograms within minutes, detecting suspicious lesions or cancerous tissues with greater accuracy than conventional screening systems.Hundreds of thousands of mammogram images were used to train the MammoScreen algorithm to recognize cancer lesions in thousands of cases. The patented MammoScreen Score provides an at-a-glance suspicion indicator of cancer from one to 10. MammoS...
Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.